zosuquidar trihydrochloride has been researched along with tariquidar in 1 studies
| Studies (zosuquidar trihydrochloride) | Trials (zosuquidar trihydrochloride) | Recent Studies (post-2010) (zosuquidar trihydrochloride) | Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 210 | 16 | 138 |
| Protein | Taxonomy | zosuquidar trihydrochloride (IC50) | tariquidar (IC50) |
|---|---|---|---|
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 0.0643 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.0841 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 7.1 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 1.2363 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, Y; Liu, XX; Qi, JG; Ren, QW; Tian, JW; Wang, BH; Wang, HB; Wang, X; Yang, YT; Zhai, R | 1 |
1 other study(ies) available for zosuquidar trihydrochloride and tariquidar
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Oleanolic Acid; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |